ADAI Webinar: Of Mice and Misuse: Preclinical Modeling of Fentanyl Use Disorder (Jan 29, 12-1pm PT)
12/30/2025
Join us on January 29th for our first ADAI Lunch & Learn of 2026!
Kevin Coffey, PhD, is a Research Assistant Professor in UW Psychiatry and Behavioral Sciences and a MIRECC Investigator at the VA Puget Sound. His lab aims to identify the neural mechanisms underlying substance use disorders and maladaptive decision making.
Dr. Coffey’s current focus is on studying the neurobiological consequences and predictors of chronic fentanyl use. To accomplish this, his lab utilizes cutting-edge in-vivo optical neuroscience tools (photometry, optogenetics, MiniScopes, etc.) along with a newly developed oral fentanyl self-administration model for rats and mice.
In this session, Kevin Coffey, PhD, a UW Research Assistant Professor, will discuss his recently funded ADAI pilot grant, which aims to explore the use of the GLP-1R agonist dulaglutide for treatment of fentanyl use disorder in his rodent models.
